{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:50:22Z","timestamp":1792979422207,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Health Science and Technology Project of Zhejiang Provincial Health Commission","award":["2022KY916"],"award-info":[{"award-number":["2022KY916"]}]},{"name":"Science Research Fund Project of Zhejiang Chinese Medical University","award":["2022FSYYZY01"],"award-info":[{"award-number":["2022FSYYZY01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-29963-7","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T20:06:55Z","timestamp":1764792415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MicroRNA21\/HDAC4 mediates podocyte apoptosis under high glucose conditions by regulating the activation of FoxO1"],"prefix":"10.1038","volume":"16","author":[{"given":"Lanjun","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"29963_CR1","doi-asserted-by":"publisher","unstructured":"Bae, J., Won, Y. J. & Lee, B. W. Non-Albumin proteinuria (NAP) as a Complementa- Ry marker for diabetic kidney disease (DKD), life (Basel).11 224. (2021). https:\/\/doi.org\/10.3390\/life11030224","DOI":"10.3390\/life11030224"},{"key":"29963_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40620-022-01365-2","volume":"36","author":"D Zha","year":"2023","unstructured":"Zha, D. & Wu, X. Nutrient sensing, signaling transduction, and autophagy in podocyte injury: implications for kidney disease. J. Nephrol. 36, 17\u201329. https:\/\/doi.org\/10.1007\/s40620-022-01365-2 (2023).","journal-title":"J. Nephrol."},{"key":"29963_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.freeradbiomed.2023.03.022","volume":"203","author":"Q Shen","year":"2023","unstructured":"Shen, Q. et al. Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE\/TFAM signaling in diabetic kidney disease. Free Radic Biol. Med. 203, 45\u201357. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.03.022 (2023).","journal-title":"Free Radic Biol. Med."},{"key":"29963_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.bbrc.2020.11.061","volume":"534","author":"L Xing","year":"2021","unstructured":"Xing, L. et al. Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes. Biochem. Biophys. Res. Commun. 534, 450\u2013456. https:\/\/doi.org\/10.1016\/j.bbrc.2020.11.061 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"29963_CR5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/cge.14256","volume":"103","author":"N Kargutkar","year":"2023","unstructured":"Kargutkar, N., Hariharan, P. & Nadkarni, A. Dynamic interplay of MicroRNA in diseases and therapeutic. Clin. Genet. 103, 268\u2013276. https:\/\/doi.org\/10.1111\/cge.14256 (2023).","journal-title":"Clin. Genet."},{"key":"29963_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10787-022-01097-6","volume":"31","author":"S Assadiasl","year":"2023","unstructured":"Assadiasl, S. et al. MicroRNAs-mediated regulation pathways in rheumatic diseases. Inflammopharmacology 31, 129\u2013144. https:\/\/doi.org\/10.1007\/s10787-022-01097-6 (2023).","journal-title":"Inflammopharmacology"},{"key":"29963_CR7","doi-asserted-by":"publisher","first-page":"e004832","DOI":"10.1136\/jitc-2022-004832","volume":"10","author":"HY Cheng","year":"2022","unstructured":"Cheng, H. Y. et al. Snail-regulated Exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance. J. Immunother Cancer. 10, e004832. https:\/\/doi.org\/10.1136\/jitc-2022-004832 (2022).","journal-title":"J. Immunother Cancer"},{"key":"29963_CR8","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s11255-023-03464-w","volume":"55","author":"N Bharti","year":"2023","unstructured":"Bharti, N. et al. miRNA-21-5p levels predict renal fibrosis and outcome in IgA nephropathy. Int. Urol. Nephrol. 55, 1557\u20131564. https:\/\/doi.org\/10.1007\/s11255-023-03464-w (2023).","journal-title":"Int. Urol. Nephrol."},{"key":"29963_CR9","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.2147\/DDDT.S170840","volume":"12","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Astragaloside iV improves renal function and fibrosis via Inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice. Drug Des. Devel Ther. 12, 2431\u20132442. https:\/\/doi.org\/10.2147\/DDDT.S170840 (2018).","journal-title":"Drug Des. Devel Ther."},{"key":"29963_CR10","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.tips.2022.09.010","volume":"43","author":"A Orea-Soufi","year":"2022","unstructured":"Orea-Soufi, A. et al. FOXO transcription factors as therapeutic targets in human diseases. Trends Pharmacol. Sci. 43, 1070\u20131084. https:\/\/doi.org\/10.1016\/j.tips.2022.09.010 (2022).","journal-title":"Trends Pharmacol. Sci."},{"key":"29963_CR11","doi-asserted-by":"publisher","first-page":"110628","DOI":"10.1016\/j.mce.2019.110628","volume":"500","author":"H Ren","year":"2020","unstructured":"Ren, H. et al. Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK\/SIRT1-FoxO1 pathway. Mol. Cell. Endocrinol. 500, 110628. https:\/\/doi.org\/10.1016\/j.mce.2019.110628 (2020).","journal-title":"Mol. Cell. Endocrinol."},{"key":"29963_CR12","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.3390\/ijms19113539","volume":"19","author":"HM Cho","year":"2018","unstructured":"Cho, H. M., Seok, Y. M., Lee, H. A., Song, M. & Kim, I. Repression of transcriptional activity of forkhead box O1 by histone deacetylase inhibitors ameliorates hyperglycemia in type 2 diabetic rats. Int. J. Mol. Sci. 19, 3539. https:\/\/doi.org\/10.3390\/ijms19113539 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"29963_CR13","doi-asserted-by":"publisher","first-page":"119068","DOI":"10.1016\/j.lfs.2021.119068","volume":"269","author":"L Xing","year":"2021","unstructured":"Xing, L. et al. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPAR\u03b3-Klotho-FoxO1 axis in diabetic nephropathy. Life Sci. 269, 119068. https:\/\/doi.org\/10.1016\/j.lfs.2021.119068 (2021).","journal-title":"Life Sci."},{"key":"29963_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejphar.2019.03.013","volume":"852","author":"J Wang","year":"2019","unstructured":"Wang, J. et al. Atrasentan alleviates high glucose-induced podocyte injury by the microRNA-21\/forkhead box O1 axis. Eur. J. Pharmacol. 852, 142\u2013150. https:\/\/doi.org\/10.1016\/j.ejphar.2019.03.013 (2019).","journal-title":"Eur. J. Pharmacol."},{"key":"29963_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2174\/1573399816","volume":"17","author":"D Roy","year":"2021","unstructured":"Roy, D. et al. MicroRNA 21 emerging role in diabetic complications: A critical update. Curr. Diabetes Rev. 17, 122\u2013135. https:\/\/doi.org\/10.2174\/1573399816- (2021).","journal-title":"Curr. Diabetes Rev."},{"key":"29963_CR16","doi-asserted-by":"publisher","unstructured":"Liu, S. et al. MicroRNA-21: A Critical Pathogenic Factor of Diabetic Nephropathy, Front Endocrinol (Lausanne). 13 895010. (2022). https:\/\/doi.org\/10.3389\/fendo.2022.895010. eCollection 2022.","DOI":"10.3389\/fendo.2022.895010"},{"key":"29963_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.23736\/S2724-6507.22.03646-6","volume":"48","author":"RG Agarwal","year":"2023","unstructured":"Agarwal, R. G. et al. A clinical and in-silico study of microRNA-21 and growth differentiation factor-15 expression in pre-diabetes, type 2 diabetes and diabetic nephropathy. Minerva Endocrinol. (Torino). 48, 172\u2013185. https:\/\/doi.org\/10.23736\/S2724-6507.22.03646-6 (2023).","journal-title":"Minerva Endocrinol. (Torino)"},{"key":"29963_CR18","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s40618-020-01401-7","volume":"44","author":"X Ding","year":"2021","unstructured":"Ding, X. et al. MiR-21-5p in macrophage-derived extracellular vesicles affects podocyte pyroptosis in diabetic nephropathy by regulating A20. J. Endocrinol. Invest. 44, 1175\u20131184. https:\/\/doi.org\/10.1007\/s40618-020-01401-7 (2021).","journal-title":"J. Endocrinol. Invest."},{"key":"29963_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/nu13010241","volume":"13","author":"R Nakamichi","year":"2021","unstructured":"Nakamichi, R., Hayashi, K. & Itoh, H. Effects of high glucose and lipotoxicity on diabetic podocytes. Nutrients 13, 241. https:\/\/doi.org\/10.3390\/nu13010241 (2021).","journal-title":"Nutrients"},{"key":"29963_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41401-021-00721-5","volume":"43","author":"XQ Liu","year":"2022","unstructured":"Liu, X. Q. et al. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease. Acta Pharmacol. Sin. 43, 96\u2013110. https:\/\/doi.org\/10.1038\/s41401-021-00721-5 (2022).","journal-title":"Acta Pharmacol. Sin"},{"key":"29963_CR21","doi-asserted-by":"publisher","first-page":"630617","DOI":"10.3389\/fphar.2021.630617","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang, Y. & He, W. Improving the dysregulation of FoxO1 activity is a potential therapy for alleviating diabetic kidney disease. Front. Pharmacol. 12, 630617. https:\/\/doi.org\/10.3389\/fphar.2021.630617 (2021).","journal-title":"Front. Pharmacol."},{"key":"29963_CR22","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.2147\/DDDT.S305016","volume":"15","author":"X Zhang","year":"2021","unstructured":"Zhang, X., Jiang, L. & Liu, H. Forkhead box protein O1: functional diversity and Post-Translational Modification, a new therapeutic target? Drug Des. Devel Ther. 15, 1851\u20131860. https:\/\/doi.org\/10.2147\/DDDT.S305016 (2021).","journal-title":"Drug Des. Devel Ther."},{"key":"29963_CR23","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.20-11.04.013","volume":"145","author":"B Wang","year":"2011","unstructured":"Wang, B. et al. Montminy. A hormone-dependent module regulating energy balance. Cell 145, 596\u2013606. https:\/\/doi.org\/10.1016\/j.cell.20-11.04.013 (2011).","journal-title":"Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29963-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29963-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29963-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:33:47Z","timestamp":1767706427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29963-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["29963"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-29963-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"562"}}